In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Amoclan Drug Master File in Korea (Amoclan KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Amoclan. The MFDS reviews the Amoclan KDMF as part of the drug registration process and uses the information provided in the Amoclan KDMF to evaluate the safety and efficacy of the drug.
After submitting a Amoclan KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Amoclan API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Amoclan suppliers with KDMF on PharmaCompass.